Mitratapide oral solution

Details for Australian Patent Application No. 2005205933 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Embrechts, Roger Carolus Augusta; Dries, Willy Maria Albert Carlo; Francois, Marc Karel Jozef

Agent Shelston IP

Pub. Number AU-B-2005205933

PCT Pub. Number WO2005/070390

Priority 04100177.7 21.01.04 EP

Filing date 18 January 2005

Wipo publication date 4 August 2005

Acceptance publication date 18 February 2010

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

Event Publications

13 July 2006 PCT application entered the National Phase

  PCT publication WO2005/070390 Priority application(s): WO2005/070390

18 February 2010 Application Accepted

  Published as AU-B-2005205933

17 June 2010 Standard Patent Sealed

3 November 2011 Assignment Registered

  Janssen Pharmaceutica N.V. The patent has been assigned to Elanco Animal Health Ireland Limited

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005205935-Quinoline derivatives and use thereof as mycobacterial inhibitors

2005205930-Pharmaceutical formulations comprising metformin and a fibrate, and processes for obtaining them